Innovative peptide for the treatment of skin burns and wounds
THE PROBLEM
0
deaths annually from burns worldwide
Most occur in low- and middle-income countries. Non-fatal burns cause disability, stigma, and long-term care costs.
-
Non-fatal burns cause major morbidity, including long hospital stays, disability, disfigurement, and social stigma.
-
Each year, millions are affected globally, with especially high numbers in low- and middle-income countries.
-
Children are heavily impacted: up to one-third of burned children suffer temporary or permanent disability.
-
Burns impose a major economic burden due to high treatment costs and long-term social and financial losses.
The solution
Advancing burn care through targeted healing
Effective burn treatment relies on the unity of systemic and topical therapy, with topical care playing a critical role in wound healing and early skin restoration. Developing innovative, accessible treatments for burns remains a key public health priority.
Dalardenol is a peptide-based burn treatment designed for direct application to affected areas. By supporting multiple biological pathways involved in tissue repair, it promotes effective healing of burn wounds and other injuries of diverse etiology.
As a topical spray, Dalardenol enables targeted delivery, ease of use, and support for timely recovery, aligning modern scientific innovation with the urgent needs of burn care.
Explore how it works
Mechanism
of Action
01
Pain relief
Modulates nociceptive response at the wound site.
02
Microbial shield
Reduces hyperinflammatory signaling and oxidative stress.
03
Research and science
Supports barrier function and limits infection risk.
04
Tissue repair
Stimulates metabolism of skin cells and promotes scarless healing.
DEVELOPMENT STATUS
Where we are today
Dalardenol supports your recovery with advanced topical therapy for burns and wounds, providing pain relief, reducing inflammation, and promoting fast, scar-minimizing skin healing.
Scalable API production
Industrial technology developed
Spray & gel formulations
Two dosage forms ready
Preclinical efficacy confirmed
High effectiveness demonstrated
Advanced topical therapy for burns and wounds
